CLBT vs. AXON

Last updated Jun 3, 2026

CLBT (Cellebrite DI Ltd.) and AXON (Axon Enterprise, Inc.) are both stocks. CLBT operates in Software - Infrastructure (Technology), while AXON operates in Aerospace & Defense (Industrials). Over the past 3 years, CLBT returned 37.92%/yr vs 36.37%/yr for AXON. At a 0.38 correlation, their price movements are largely independent.

Performance

CLBT vs. AXON - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Cellebrite DI Ltd. (CLBT) and Axon Enterprise, Inc. (AXON). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, CLBT achieves a -16.92% return, which is significantly lower than AXON's -13.70% return.

CLBT

• 1D: -5.61%
• 1M: 12.21%
• YTD: -16.92%
• 6M: -15.89%
• 1Y: -8.38%
• 3Y*: 37.92%
• 5Y*: —
• 10Y*: —

AXON

• 1D: 2.78%
• 1M: 21.83%
• YTD: -13.70%
• 6M: -8.86%
• 1Y: -35.39%
• 3Y*: 36.37%
• 5Y*: 28.81%
• 10Y*: 35.93%

*Multi-year figures are annualized to reflect compound growth (CAGR)

CLBT vs. AXON - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021
CLBT Cellebrite DI Ltd.	-16.92%	-18.16%	154.39%	98.62%	-45.64%	-21.76%
AXON Axon Enterprise, Inc.	-13.70%	-4.44%	130.06%	55.69%	5.69%	-13.67%

Correlation

The correlation between CLBT and AXON is 0.39, which is low. Their price movements are largely independent, making them effective diversification partners.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.39
Correlation (3Y) Calculated over the trailing 3-year period	0.40
Correlation (All Time) Calculated using the full available price history since Sep 1, 2021	0.38

Fundamentals

Market Cap CLBT : $3.78B AXON : $40.42B
EPS CLBT : $0.29 AXON : $2.41
PE Ratio CLBT : 52.23 AXON : 203.75
PEG Ratio CLBT : 0.10 AXON : 0.06
PS Ratio CLBT : 7.56 AXON : 14.09
PB Ratio CLBT : 7.40 AXON : 11.44
Total Revenue (TTM) CLBT : $496.43M AXON : $2.98B
Gross Profit (TTM) CLBT : $416.33M AXON : $1.77B
EBITDA (TTM) CLBT : $84.98M AXON : $156.24M

Return for Risk

CLBT vs. AXON — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

CLBT

CLBT Risk / Return Rank: 32
CLBT Sharpe Ratio Rank: 33
CLBT Sortino Ratio Rank: 32
CLBT Omega Ratio Rank: 32
CLBT Calmar Ratio Rank: 32
CLBT Martin Ratio Rank: 31

AXON

AXON Risk / Return Rank: 16
AXON Sharpe Ratio Rank: 13
AXON Sortino Ratio Rank: 14
AXON Omega Ratio Rank: 15
AXON Calmar Ratio Rank: 20
AXON Martin Ratio Rank: 20

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

CLBT vs. AXON - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Cellebrite DI Ltd. (CLBT) and Axon Enterprise, Inc. (AXON). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	CLBT	AXON	Difference
Sharpe ratio Return per unit of total volatility	-0.16	-0.65	+0.48
Sortino ratio Return per unit of downside risk	0.12	-0.74	+0.87
Omega ratio Gain probability vs. loss probability	1.01	0.90	+0.11
Calmar ratio Return relative to maximum drawdown	-0.23	-0.58	+0.34
Martin ratio Return relative to average drawdown	-0.52	-1.01	+0.49
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

CLBT vs. AXON - Sharpe Ratio Comparison

The current CLBT Sharpe Ratio is -0.16, which is higher than the AXON Sharpe Ratio of -0.65. The chart below compares the historical Sharpe Ratios of CLBT and AXON, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Sharpe Ratios by Period

	CLBT	AXON	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	-0.16	-0.65	+0.48
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	—	0.61	—
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	—	0.73	—
Sharpe Ratio (All Time) Calculated using the full available price history	0.17	0.52	-0.35

Drawdowns

CLBT vs. AXON - Drawdown Comparison

The maximum CLBT drawdown since its inception was -67.74%, smaller than the maximum AXON drawdown of -91.78%. Use the drawdown chart below to compare losses from any high point for CLBT and AXON.

Drawdown Indicators

	CLBT	AXON	Difference
Max Drawdown Largest peak-to-trough decline	-67.74%	-91.78%	+24.04%
Max Drawdown (1Y) Largest decline over 1 year	-43.61%	-60.28%	+16.67%
Max Drawdown (3Y) Largest decline over 3 years	-57.58%	-60.28%	+2.70%
Max Drawdown (5Y) Largest decline over 5 years	—	-60.28%	—
Max Drawdown (10Y) Largest decline over 10 years	—	-60.28%	—
Current Drawdown Current decline from peak	-42.38%	-43.73%	+1.35%
Average Drawdown Average peak-to-trough decline	-34.47%	-43.59%	+9.12%
Ulcer Index Depth and duration of drawdowns from previous peaks	19.55%	34.36%	-14.81%

Volatility

CLBT vs. AXON - Volatility Comparison

Cellebrite DI Ltd. (CLBT) has a higher volatility of 20.75% compared to Axon Enterprise, Inc. (AXON) at 19.65%. This indicates that CLBT's price experiences larger fluctuations and is considered to be riskier than AXON based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	CLBT	AXON	Difference
Volatility (1M) Calculated over the trailing 1-month period	20.75%	19.65%	+1.10%
Volatility (6M) Calculated over the trailing 6-month period	39.81%	43.33%	-3.52%
Volatility (1Y) Calculated over the trailing 1-year period	51.31%	54.97%	-3.66%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	50.33%	47.86%	+2.47%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	50.33%	49.11%	+1.22%

Dividends

CLBT vs. AXON - Dividend Comparison

Neither CLBT nor AXON has paid dividends to shareholders.

Tickers have no history of dividend payments

Financials

CLBT vs. AXON - Profitability Comparison

The chart below illustrates the profitability comparison between Cellebrite DI Ltd. and Axon Enterprise, Inc. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

CLBT - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Cellebrite DI Ltd. reported a gross profit of 105.88M and revenue of 128.30M. Therefore, the gross margin over that period was 82.5%.

AXON - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Axon Enterprise, Inc. reported a gross profit of 477.29M and revenue of 807.35M. Therefore, the gross margin over that period was 59.1%.

CLBT - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Cellebrite DI Ltd. reported an operating income of 9.23M and revenue of 128.30M, resulting in an operating margin of 7.2%.

AXON - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Axon Enterprise, Inc. reported an operating income of 29.24M and revenue of 807.35M, resulting in an operating margin of 3.6%.

CLBT - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Cellebrite DI Ltd. reported a net income of 10.94M and revenue of 128.30M, resulting in a net margin of 8.5%.

AXON - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Axon Enterprise, Inc. reported a net income of 169.31M and revenue of 807.35M, resulting in a net margin of 21.0%.

Frequently Asked Questions

Can I hold both CLBT and AXON in my portfolio?

CLBT and AXON have a correlation of 0.39, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, CLBT or AXON?

CLBT has higher volatility (20.75%) compared to AXON (19.65%). In terms of maximum drawdown, CLBT dropped -67.74% vs AXON's -91.78%.

Which has better risk-adjusted returns?

CLBT currently has the higher Sharpe Ratio (-0.16 vs -0.65), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.